Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2022-12-28 Regulatory Filings
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notice titled 'Notice of Closure of Trading Window' addressed to stock exchanges, referencing SEBI (Prohibition of Insider Trading) Regulations, 2015. It informs about the closure of the trading window from January 1, 2023, until 48 hours after the announcement of financial results for the quarter and nine months ending December 31, 2022. The document is short (1596 characters) and serves as an announcement related to insider trading compliance rather than containing any financial data or report. It does not contain financial statements or detailed financial analysis. Therefore, it is not an Interim/Quarterly Report or Earnings Release. It is also not a regulatory filing in the sense of officer certifications or compliance documents but rather a regulatory announcement related to trading restrictions. Given the options, the best fit is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2022-12-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges about the schedule of upcoming analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations. The content is an announcement of meeting schedules, not a report or transcript of the meetings themselves. It does not contain financial data, management discussion, or detailed presentations. The document length is only 1539 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2022-12-19 English
Postal Ballot
Regulatory Filings
2022-12-15 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a short notice dated December 14, 2022, addressed to stock exchanges, informing about the schedule of an upcoming analyst/institutional investor meeting (conference call) on December 15, 2022. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The document does not contain any financial data, results, or detailed report content. It is an announcement of a scheduled investor meeting rather than a transcript or report. Given the content and length (1714 characters), it fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about an event and does not fall into more specific categories like Call Transcript or Investor Presentation, which would be more detailed and substantive.
2022-12-14 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a short notice dated December 7, 2022, addressed to stock exchanges, informing them about the schedule of upcoming analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The content is purely an announcement of scheduled meetings (conference call and one-on-one meeting) with no financial data, no report attached or referenced as being published, and no detailed financial or management discussion. The document length is only 1785 characters, which is very short and fits the pattern of an announcement rather than a full report or transcript. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-12-07 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a short notice dated December 5, 2022, addressed to stock exchanges, informing about the schedule of analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is purely an announcement of upcoming investor meetings (conference calls and one-on-one meetings) and explicitly states no unpublished price sensitive information will be shared. The document length is 1948 characters, which is short and does not contain any financial data, report, or detailed presentation. It is not a financial report, earnings release, or management discussion. It is an announcement related to investor relations activities. Therefore, the document fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-12-05 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.